SurgVision Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Investors
-
1
SurgVision General Information
Description
Developer of molecular surgical imaging technology designed to discriminate between healthy and cancerous tissue. The company develops intraoperative imaging systems, near-infrared fluorescence devices, targeted imaging agents, clinical validation support, regulatory documentation, and technology platforms for real-time tumor visualization during surgery.
Contact Information
Website
www.surgvision.com(Operating Subsidiary)
Corporate Office
- Kistlerhofstr. 70
- Geb. 79
- 81379 Munich
- Germany
Corporate Office
- Kistlerhofstr. 70
- Geb. 79
- 81379 Munich
- Germany
SurgVision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 18-Oct-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 19-Dec-2014 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Aug-2013 | Completed | Startup |
SurgVision Patents
SurgVision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026510742-A | Cooling system for the imaging head of a fluorescence imaging device | Pending | 14-Mar-2023 | ||
| EP-4680094-A1 | Cooling system of an imaging head of a fluorescence imaging apparatus | Pending | 14-Mar-2023 | ||
| WO-2024189097-A1 | Cooling system of an imaging head of a fluorescence imaging apparatus | Inactive | 14-Mar-2023 | ||
| JP-2026500611-A | Motion-corrected background subtraction for fluorescence imaging | Pending | 30-Dec-2022 | ||
| EP-4642310-A1 | Motion-stabilized background subtraction for fluorescence imaging | Pending | 30-Dec-2022 | A61B1/000095 |
SurgVision Signals
SurgVision Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascenion | Accelerator/Incubator | Minority | ||
| BioGeneration Ventures | Venture Capital | Minority | ||
| DFZ Participaties | Venture Capital | Minority | ||
| Mibiton | Venture Capital | Minority |
SurgVision FAQs
-
When was SurgVision founded?
SurgVision was founded in 2013.
-
Where is SurgVision headquartered?
SurgVision is headquartered in Munich, Germany.
-
What is the size of SurgVision?
SurgVision has 8 total employees.
-
What industry is SurgVision in?
SurgVision’s primary industry is Diagnostic Equipment.
-
Is SurgVision a private or public company?
SurgVision is a Private company.
-
What is SurgVision’s current revenue?
The current revenue for SurgVision is .
-
Who are SurgVision’s investors?
Ascenion, BioGeneration Ventures, DFZ Participaties, and Mibiton have invested in SurgVision.
-
When was SurgVision acquired?
SurgVision was acquired on 18-Oct-2017.
-
Who acquired SurgVision?
SurgVision was acquired by Blue Earth Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process